Hina Khan, MD

Published Articles (1)

FDA Approves New Drug for HER2-Positive, PD-L1-Expressing Gastric/Gastroesophageal Adenocarcinoma

April 28, 2026

Lung cancer screening saves lives, yet disparities persist. Dr. Hina Khan explores barriers to low-dose CT access and community-driven solutions to improve early detection and equity.